| 1 |
30758990 | Prostaglandin E2 inhibits profibrotic function of human pulmonary fibroblasts by disrupting Ca2+ signaling. | 2019 May 1 |
1 |
| 2 |
28472126 | Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells. | 2017 |
1 |
| 3 |
25595899 | Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation. | 2015 Jan 30 |
1 |
| 4 |
26342086 | Differential deposition of fibronectin by asthmatic bronchial epithelial cells. | 2015 Nov 15 |
1 |
| 5 |
24687862 | Fibronectin enhances spinal cord astrocyte proliferation by elevating P2Y1 receptor expression. | 2014 Aug |
1 |
| 6 |
24098479 | TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1. | 2013 |
1 |
| 7 |
18459145 | Modulation of cyclooxygenase in endothelial cells by fibronectin: relevance to angiogenesis. | 2008 Sep 1 |
2 |
| 8 |
17237224 | Extracellular matrix fibronectin increases prostaglandin E2 receptor subtype EP4 in lung carcinoma cells through multiple signaling pathways: the role of AP-2. | 2007 Mar 16 |
2 |
| 9 |
16711067 | Substrate modulation of osteoblast adhesion strength, focal adhesion kinase activation, and responsiveness to mechanical stimuli. | 2006 Mar |
2 |
| 10 |
15525653 | Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation. | 2005 Jan 14 |
1 |
| 11 |
15004000 | Formation of focal adhesions on fibronectin promotes fluid shear stress induction of COX-2 and PGE2 release in MC3T3-E1 osteoblasts. | 2004 Jul |
2 |
| 12 |
15120641 | Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma. | 2004 May 28 |
1 |
| 13 |
15221958 | Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression. | 2004 Sep 1 |
3 |
| 14 |
11597918 | Prostaglandin E(2) inhibits fibroblast chemotaxis. | 2001 Nov |
1 |
| 15 |
10577614 | Prediction of cervical response to prostaglandin E2 using fetal fibronectin. | 1999 Nov |
4 |
| 16 |
9539523 | Cervical fetal fibronectin correlates to prostaglandin E2-induced cervical ripening and can be identified in cervical tissue. | 1998 Mar |
5 |
| 17 |
7572103 | Cervical fetal fibronectin correlates to cervical ripening. | 1995 Oct |
1 |
| 18 |
7594454 | Enhancement of VLA integrin receptor function on thymocytes by cAMP is dependent on the maturation stage of the thymocytes. | 1995 Nov 15 |
1 |
| 19 |
1751108 | Fibronectin surface density affects endothelial cell function and growth on hydrophilic polymer. | 1991 Jul-Sep |
1 |
| 20 |
2146129 | Etodolac preserves cartilage-specific phenotype in human chondrocytes: effects on type II collagen synthesis and associated mRNA levels. | 1990 |
1 |
| 21 |
2222195 | [The effects of various drugs and immune complexes on the function of alveolar macrophages from patients with collagen-vascular diseases with interstitial pneumonia]. | 1990 Jun |
1 |
| 22 |
2327658 | Regulatory effect of prostaglandin E2 on fibronectin release from human alveolar macrophages. | 1990 Apr |
8 |
| 23 |
2625810 | [Production of fibronectin and PGE2 by cultured human alveolar macrophages]. | 1989 Nov |
4 |
| 24 |
3478047 | PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. | 1987 Sep 30 |
3 |
| 25 |
2870582 | Connective tissue components in synovial fibroblast cultures exposed to interleukin 1 and prostaglandin E2. | 1986 |
1 |
| 26 |
3081573 | Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. | 1986 Mar |
2 |
| 27 |
2988854 | Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin. | 1985 Mar |
1 |